12.19.23 -- New Developments In mRNA Vaccine Efficacy Show Promise

Recognizing what it takes to complete technology transfers effectively and efficiently is crucial to selecting the best partner for your project and product needs.

Learning more about spray drying, as well as two case studies detailing its success, serves as a critical tool in developing innovative and effective lung cancer therapies.

We demonstrate how to reduce the time taken to develop a binding ELISA from over five runs to just two runs for both IgG monoclonal antibodies and Fc fusion proteins.

As the industry looks forward, key decision makers in pharma and biotech companies were surveyed to assess their views on undertaking regulatory processes virtually.

Devoting early-phase resources for solid form understanding and screening during a drug’s development life cycle is critical, as doing so can help save time and resources on the path to market.

Discover highly promising in-vivo data, enabled by a nanoformed drug product for the treatment of glioblastoma multiforme (GBM).

When preparing for IND submission, developers must consider multiple components. Explore tips for optimizing your early development program and the benefits of housing all activities under one roof.